{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T08:03:07Z","timestamp":1785225787744,"version":"3.55.0"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T00:00:00Z","timestamp":1779148800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007046","name":"Greater Milwaukee Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007046","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011541","name":"National Cancer Institute Division of Cancer Epidemiology and Genetics","doi-asserted-by":"publisher","award":["1R15CA277656-01"],"award-info":[{"award-number":["1R15CA277656-01"]}],"id":[{"id":"10.13039\/100011541","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006817","name":"University of Wisconsin-Milwaukee","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006817","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Redox Biology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.redox.2026.104229","type":"journal-article","created":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T15:26:49Z","timestamp":1780586809000},"page":"104229","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Exploiting vitamin C as a prooxidant to activate ROS-responsive prodrugs for potent and selective tumor killing"],"prefix":"10.1016","volume":"95","author":[{"given":"Taufeeque","family":"Ali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thilini Nimasha Fernando","family":"Ponnamperumage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cody Joshua","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wasiu Olaniyi","family":"Awoyera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexis Kimberly","family":"Peterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanlun","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jatin","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia Anna Rose","family":"Jakusz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heli","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilbert Edward","family":"Koelsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leggy A.","family":"Arnold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie M.","family":"Jorns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yee Chung","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avik","family":"Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5627-0606","authenticated-orcid":false,"given":"Xiaohua","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.redox.2026.104229_bib1","doi-asserted-by":"crossref","first-page":"479","DOI":"10.3109\/10715761003667554","article-title":"Reactive oxygen species in cancer","volume":"44","author":"Liou","year":"2010","journal-title":"Free Radic. Res."},{"key":"10.1016\/j.redox.2026.104229_bib2","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/nrd4002","article-title":"Modulation of oxidative stress as an anticancer strategy","volume":"12","author":"Gorrini","year":"2013","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.redox.2026.104229_bib3","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/nrd2803","article-title":"Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?","volume":"8","author":"Trachootham","year":"2009","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.redox.2026.104229_bib4","doi-asserted-by":"crossref","first-page":"4309","DOI":"10.1158\/1078-0432.CCR-12-1424","article-title":"Molecular pathways: reactive oxygen species homeostasis in cancer cells and implications for cancer therapy","volume":"19","author":"Nogueira","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.redox.2026.104229_bib5","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ccr.2006.08.015","article-title":"Reactive oxygen species in cancer cells: live by the sword, die by the sword","volume":"10","author":"Schumacker","year":"2006","journal-title":"Cancer Cell"},{"key":"10.1016\/j.redox.2026.104229_bib6","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.4161\/cbt.7.12.7067","article-title":"Cancer cell killing via ROS: to increase or decrease, that is the question","volume":"7","author":"Wang","year":"2008","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.redox.2026.104229_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16122171","article-title":"Generation of hydrogen peroxide in cancer cells: advancing therapeutic approaches for cancer treatment","volume":"16","author":"Ali","year":"2024","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.redox.2026.104229_bib8","doi-asserted-by":"crossref","first-page":"11105","DOI":"10.1073\/pnas.0804226105","article-title":"Pharmacologic doses of ascorbate act as a prooxidant and decrease growth of aggressive tumor xenografts in mice","volume":"105","author":"Chen","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.redox.2026.104229_bib9","doi-asserted-by":"crossref","first-page":"13604","DOI":"10.1073\/pnas.0506390102","article-title":"Pharmacologic ascorbic acid concentrations selectively kill cancer cells: action as a pro-drug to deliver hydrogen peroxide to tissues","volume":"102","author":"Chen","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.redox.2026.104229_bib10","doi-asserted-by":"crossref","first-page":"8749","DOI":"10.1073\/pnas.0702854104","article-title":"Ascorbate in pharmacologic concentrations selectively generates ascorbate radical and hydrogen peroxide in extracellular fluid in vivo","volume":"104","author":"Chen","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.redox.2026.104229_bib11","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1126\/science.aaa5004","article-title":"Vitamin C selectively kills KRAS and BRAF mutant colorectal cancer cells by targeting GAPDH","volume":"350","author":"Yun","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.redox.2026.104229_bib12","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1039\/C9MD00169G","article-title":"Prodrug strategies for targeted therapy triggered by reactive oxygen species","volume":"10","author":"Peiro Cadahia","year":"2019","journal-title":"Medchemcomm"},{"key":"10.1016\/j.redox.2026.104229_bib13","doi-asserted-by":"crossref","DOI":"10.1002\/cbic.202100366","article-title":"Recent advances in hydrogen peroxide responsive organoborons for biological and biomedical applications","volume":"23","author":"Saxon","year":"2022","journal-title":"Chembiochem"},{"key":"10.1016\/j.redox.2026.104229_bib14","doi-asserted-by":"crossref","first-page":"8278","DOI":"10.1073\/pnas.1506761112","article-title":"Leinamycin E1 acting as an anticancer prodrug activated by reactive oxygen species","volume":"112","author":"Huang","year":"2015","journal-title":"P Natl Acad Sci USA"},{"key":"10.1016\/j.redox.2026.104229_bib15","doi-asserted-by":"crossref","first-page":"19278","DOI":"10.1021\/ja2073824","article-title":"Hydrogen peroxide inducible DNA cross-linking agents: targeted anticancer prodrugs","volume":"133","author":"Kuang","year":"2011","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.redox.2026.104229_bib16","doi-asserted-by":"crossref","first-page":"823","DOI":"10.4155\/tde.12.61","article-title":"ROS-activated anticancer prodrugs: a new strategy for tumor-specific damage","volume":"3","author":"Peng","year":"2012","journal-title":"Ther. Deliv."},{"key":"10.1016\/j.redox.2026.104229_bib17","doi-asserted-by":"crossref","first-page":"9132","DOI":"10.1021\/acs.jmedchem.8b00559","article-title":"Discovery and optimization of novel hydrogen peroxide activated aromatic nitrogen mustard derivatives as highly potent anticancer agents","volume":"61","author":"Chen","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.redox.2026.104229_bib18","doi-asserted-by":"crossref","first-page":"4498","DOI":"10.1021\/jm401349g","article-title":"Reactive oxygen species (ROS) inducible DNA cross-linking agents and their effect on cancer cells and normal lymphocytes","volume":"57","author":"Chen","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.redox.2026.104229_bib19","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1021\/jm2014937","article-title":"Aminoferrocene-based prodrugs activated by reactive oxygen species","volume":"55","author":"Hagen","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.redox.2026.104229_bib20","doi-asserted-by":"crossref","first-page":"3447","DOI":"10.1016\/j.bmcl.2015.07.013","article-title":"Activity of aminoferrocene-based prodrugs against prostate cancer","volume":"25","author":"Schikora","year":"2015","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.redox.2026.104229_bib21","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1002\/anie.201706585","article-title":"Lysosome-targeting amplifiers of reactive oxygen species as anticancer prodrugs","volume":"56","author":"Daum","year":"2017","journal-title":"Angew Chem. Int. Ed. Engl."},{"key":"10.1016\/j.redox.2026.104229_bib22","doi-asserted-by":"crossref","first-page":"11943","DOI":"10.1002\/anie.201805955","article-title":"ROS-responsive N-Alkylaminoferrocenes for cancer-cell-specific targeting of mitochondria","volume":"57","author":"Reshetnikov","year":"2018","journal-title":"Angew Chem. Int. Ed. Engl."},{"key":"10.1016\/j.redox.2026.104229_bib23","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20102469","article-title":"Tumor-specific reactive oxygen species accelerators improve chimeric antigen receptor T cell therapy in B cell malignancies","volume":"20","author":"Yoo","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.redox.2026.104229_bib24","first-page":"7410","article-title":"Aromatic nitrogen mustard-based prodrugs: activity, selectivity, and the mechanism of DNA cross-linking","volume":"20","author":"Chen","year":"2014","journal-title":"Chemistry (Easton)"},{"key":"10.1016\/j.redox.2026.104229_bib25","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1021\/acsptsci.0c00092","article-title":"Assessment of phenylboronic acid nitrogen mustards as potent and selective drug candidates for triple-negative breast cancer","volume":"4","author":"Fan","year":"2021","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"10.1016\/j.redox.2026.104229_bib26","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.ejmech.2017.03.041","article-title":"Hydrogen peroxide activated quinone methide precursors with enhanced DNA cross-linking capability and cytotoxicity towards cancer cells","volume":"133","author":"Wang","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.redox.2026.104229_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116695","article-title":"Hydrogen peroxide responsive theranostics for cancer-selective activation of DNA alkylators and real-time fluorescence monitoring in living cells","volume":"276","author":"Saxon","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.redox.2026.104229_bib28","doi-asserted-by":"crossref","first-page":"25026","DOI":"10.1021\/acs.jmedchem.5c01975","article-title":"H(2)O(2)-Responsive anticancer prodrug: synthesis, precision deuteration in search of in vivo metabolites, and activation pathway","volume":"68","author":"Saxon","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.redox.2026.104229_bib29","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0065-2571(84)90007-4","article-title":"Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors","volume":"22","author":"Chou","year":"1984","journal-title":"Adv. Enzym. Regul."},{"key":"10.1016\/j.redox.2026.104229_bib30","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/0165-6147(83)90490-X","article-title":"Analysis of combined drug effects: a new look at a very old problem","volume":"4","author":"Chou Tc","year":"1983","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.redox.2026.104229_bib31","doi-asserted-by":"crossref","first-page":"W739","DOI":"10.1093\/nar\/gkac382","article-title":"SynergyFinder 3.0: an interactive analysis and consensus interpretation of multi-drug synergies across multiple samples","volume":"50","author":"Ianevski","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.redox.2026.104229_bib32","doi-asserted-by":"crossref","first-page":"187","DOI":"10.3109\/10428199609054821","article-title":"Chlorambucil in chronic lymphocytic leukemia: mechanism of action","volume":"23","author":"Begleiter","year":"1996","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.redox.2026.104229_bib33","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.redox.2017.08.017","article-title":"Augmentation of intracellular iron using iron sucrose enhances the toxicity of pharmacological ascorbate in colon cancer cells","volume":"14","author":"Brandt","year":"2018","journal-title":"Redox Biol."},{"key":"10.1016\/j.redox.2026.104229_bib34","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.redox.2017.09.012","article-title":"Redox active metals and H(2)O(2) mediate the increased efficacy of pharmacological ascorbate in combination with gemcitabine or radiation in pre-clinical sarcoma models","volume":"14","author":"Schoenfeld","year":"2018","journal-title":"Redox Biol."},{"key":"10.1016\/j.redox.2026.104229_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2023.102651","article-title":"Magnetite nanoparticles as a kinetically favorable source of iron to enhance GBM response to chemoradiosensitization with pharmacological ascorbate","volume":"62","author":"Petronek","year":"2023","journal-title":"Redox Biol."},{"key":"10.1016\/j.redox.2026.104229_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2020.101804","article-title":"Magnetic resonance imaging (MRI) of pharmacological ascorbate-induced iron redox state as a biomarker in subjects undergoing radio-chemotherapy","volume":"38","author":"Cushing","year":"2021","journal-title":"Redox Biol."},{"key":"10.1016\/j.redox.2026.104229_bib37","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.ccell.2017.02.018","article-title":"O(2)(\u22c5-) and H(2)O(2)-Mediated disruption of Fe metabolism causes the differential susceptibility of NSCLC and GBM cancer cells to pharmacological ascorbate","volume":"31","author":"Schoenfeld","year":"2017","journal-title":"Cancer Cell"},{"key":"10.1016\/j.redox.2026.104229_bib38","doi-asserted-by":"crossref","first-page":"43ra56","DOI":"10.1126\/scitranslmed.3001127","article-title":"Ferroportin and iron regulation in breast cancer progression and prognosis","volume":"2","author":"Pinnix","year":"2010","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.redox.2026.104229_bib39","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.3390\/nu5082836","article-title":"Iron deprivation in cancer--potential therapeutic implications","volume":"5","author":"Heath","year":"2013","journal-title":"Nutrients"},{"key":"10.1016\/j.redox.2026.104229_bib40","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0161079","article-title":"Establishment of early endpoints in mouse total-body irradiation model","volume":"11","author":"Koch","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.redox.2026.104229_bib41","first-page":"234","article-title":"Endpoints for mouse abdominal tumor models: refinement of current criteria","volume":"59","author":"Paster","year":"2009","journal-title":"Comp. Med."},{"key":"10.1016\/j.redox.2026.104229_bib42","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.ccell.2015.01.007","article-title":"Reactive oxygen species in cancer: a dance with the devil","volume":"27","author":"Schumacker","year":"2015","journal-title":"Cancer Cell"},{"key":"10.1016\/j.redox.2026.104229_bib43","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.ccell.2018.07.014","article-title":"Ascorbic acid in cancer treatment: let the phoenix fly","volume":"34","author":"Shenoy","year":"2018","journal-title":"Cancer Cell"},{"key":"10.1016\/j.redox.2026.104229_bib44","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0011414","article-title":"Vitamin C: intravenous use by complementary and alternative medicine practitioners and adverse effects","volume":"5","author":"Padayatty","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.redox.2026.104229_bib45","first-page":"443","article-title":"Ascorbic acid: chemistry, biology and the treatment of cancer","volume":"1826","author":"Du","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.redox.2026.104229_bib46","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s00280-013-2070-8","article-title":"Pharmacological ascorbate with gemcitabine for the control of metastatic and node-positive pancreatic cancer (PACMAN): results from a phase I clinical trial","volume":"71","author":"Welsh","year":"2013","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.redox.2026.104229_bib47","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0120228","article-title":"High-dose intravenous vitamin C combined with cytotoxic chemotherapy in patients with advanced cancer: a phase I-II clinical trial","volume":"10","author":"Hoffer","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.redox.2026.104229_bib48","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3007154","article-title":"High-dose parenteral ascorbate enhanced chemosensitivity of ovarian cancer and reduced toxicity of chemotherapy","volume":"6","author":"Ma","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.redox.2026.104229_bib49","doi-asserted-by":"crossref","first-page":"6838","DOI":"10.1158\/0008-5472.CAN-18-1680","article-title":"Pharmacologic ascorbate reduces radiation-induced normal tissue toxicity and enhances tumor radiosensitization in pancreatic cancer","volume":"78","author":"Alexander","year":"2018","journal-title":"Cancer Res."},{"key":"10.1016\/j.redox.2026.104229_bib50","doi-asserted-by":"crossref","first-page":"6590","DOI":"10.1158\/1078-0432.CCR-19-0594","article-title":"First-in-Human phase I clinical trial of pharmacologic ascorbate combined with radiation and temozolomide for newly diagnosed glioblastoma","volume":"25","author":"Allen","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.redox.2026.104229_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2022.102318","article-title":"Pharmacological ascorbate improves the response to platinum-based chemotherapy in advanced stage non-small cell lung cancer","volume":"53","author":"Furqan","year":"2022","journal-title":"Redox Biol."},{"key":"10.1016\/j.redox.2026.104229_bib52","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1158\/1078-0432.CCR-22-3952","article-title":"Magnetic resonance imaging of iron metabolism with T2* mapping predicts an enhanced clinical response to pharmacologic ascorbate in patients with GBM","volume":"30","author":"Petronek","year":"2024","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.redox.2026.104229_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2024.103375","article-title":"A randomized trial of pharmacological ascorbate, gemcitabine, and nab-paclitaxel for metastatic pancreatic cancer","volume":"77","author":"Bodeker","year":"2024","journal-title":"Redox Biol."},{"key":"10.1016\/j.redox.2026.104229_bib54","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1056\/NEJM198501173120301","article-title":"High-dose vitamin C versus placebo in the treatment of patients with advanced cancer who have had no prior chemotherapy. A randomized double-blind comparison","volume":"312","author":"Moertel","year":"1985","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.redox.2026.104229_bib55","first-page":"215","article-title":"Vitamin C and cancer: what can we conclude--1,609 patients and 33 years later?","volume":"29","author":"Cabanillas","year":"2010","journal-title":"Puert. Rico Health Sci. J."},{"key":"10.1016\/j.redox.2026.104229_bib56","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0029794","article-title":"Phase I evaluation of intravenous ascorbic acid in combination with gemcitabine and erlotinib in patients with metastatic pancreatic cancer","volume":"7","author":"Monti","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.redox.2026.104229_bib57","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.1158\/2767-9764.CRC-24-0225","article-title":"High-dose intravenous vitamin C combined with docetaxel in men with metastatic castration-resistant prostate cancer: a randomized placebo-controlled phase II trial","volume":"4","author":"Paller","year":"2024","journal-title":"Cancer Res. Commun."},{"key":"10.1016\/j.redox.2026.104229_bib58","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-019-1170-y","article-title":"CD8(+) T cells regulate tumour ferroptosis during cancer immunotherapy","volume":"569","author":"Wang","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.redox.2026.104229_bib59","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/j.cell.2016.04.009","article-title":"Effector T cells abrogate stroma-mediated chemoresistance in ovarian cancer","volume":"165","author":"Wang","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.redox.2026.104229_bib60","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.cmet.2018.05.012","article-title":"Alteration of tumor metabolism by CD4+ T cells leads to TNF-alpha-Dependent intensification of oxidative stress and tumor cell death","volume":"28","author":"Habtetsion","year":"2018","journal-title":"Cell Metab."},{"key":"10.1016\/j.redox.2026.104229_bib61","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11091301","article-title":"Immunotherapy with monoclonal antibodies in lung cancer of mice: oxidative stress and other biological events","volume":"11","author":"Tang","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.redox.2026.104229_bib62","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-004938","article-title":"Indomethacin-induced oxidative stress enhances death receptor 5 signaling and sensitizes tumor cells to adoptive T-cell therapy","volume":"10","author":"Aboelella","year":"2022","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.redox.2026.104229_bib63","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13050986","article-title":"Oxidative stress in the tumor microenvironment and its relevance to cancer immunotherapy","volume":"13","author":"Aboelella","year":"2021","journal-title":"Cancers (Basel)"}],"container-title":["Redox Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213231726002272?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213231726002272?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T07:51:15Z","timestamp":1785225075000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213231726002272"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":63,"alternative-id":["S2213231726002272"],"URL":"https:\/\/doi.org\/10.1016\/j.redox.2026.104229","relation":{},"ISSN":["2213-2317"],"issn-type":[{"value":"2213-2317","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploiting vitamin C as a prooxidant to activate ROS-responsive prodrugs for potent and selective tumor killing","name":"articletitle","label":"Article Title"},{"value":"Redox Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.redox.2026.104229","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"104229"}}